Cannibite BV is a dental biotechnology firm that develops cannabinoid-based oral care products. Led by Dr. Veronica Stahl, it uses patented formulas combining cannabinoids and Dead Sea salt to promote dental hygiene and treat oral ailments.
Cannibite BV is a biotechnology and dental health company that specializes in developing innovative oral care products by integrating cannabinoids with natural therapeutic minerals, such as Dead Sea salt. Founded by Dr. Veronica Stahl, a dental practitioner with extensive experience in implantology, the company utilizes proprietary formulations to improve dental hygiene and address conditions like dental pulp-associated diseases. Their approach focuses on reducing harmful oral microflora through non-invasive, plant-based treatments, supported by clinical research and multiple patents. The company operates at the intersection of the pharmaceutical and oral care sectors, aiming to bring sustainable, nature-based dental solutions to the market.
By leveraging the therapeutic potential of the endocannabinoid system, Cannibite provides specialized products such as fluoride-free toothpaste and mouthwash, which have been evaluated for their efficacy in managing dental plaque buildup. Their work is intended for both dental professionals and patients, offering an alternative to traditional over-the-counter oral hygiene products. Through collaborative research and strategic partnerships, the company seeks to commercialize its patented medical-grade compositions, aiming to establish new standards for preventive and therapeutic oral healthcare while expanding the role of cannabinoids in professional dentistry.